RxDoctor Payments Data

Jeremy Shaw

Orthopaedic Surgery · Pittsburgh, PANPI 1770859654

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $11,839 of the $19,582 with a category attached, or 60.5%. 9 manufacturers reported payments, led by Synthes GmbH at 45.9% of the total.

$19,582in general payments, 2019–2025

Across 74 payments — averaging $264.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Synthes GmbH$9K
  • Globus Medical$6K
  • Stryker$3K
  • Centinel Spine, LLC$933
  • Medtronic$279
  • Alphatec Spine, Inc$174
  • plus $334 from 3 others
$5,000in research payments, 2019–2025

Across 1 payment — averaging $5000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$5K

What the payments were for

  • Consulting fees$1,3007%
  • Speaking & faculty fees$3,50018%
  • Travel & lodging$11,83960%
  • Food & beverage$2,89915%
  • Entertainment$450%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,582 in reported general payments places this provider in the 80th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.

See all orthopaedic surgery providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$34,311
Medicare patients
75
Services billed
137

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin93$1,105
Pregabalin16$279
Diclofenac Sodium27$273
Meloxicam65$194
Methylprednisolone14$92
Cyclobenzaprine Hcl24$91

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Pittsburgh

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →